AirSculpt Technologies (NASDAQ:AIRS) Raised to Hold at Wall Street Zen

AirSculpt Technologies (NASDAQ:AIRS) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Sunday.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $6.00.

AirSculpt Technologies Stock Performance

Shares of AirSculpt Technologies stock opened at $3.10 on Friday. The stock’s fifty day moving average is $2.34 and its two-hundred day moving average is $4.32. The company has a market capitalization of $218.71 million, a PE ratio of -16.31 and a beta of 2.22. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63. AirSculpt Technologies has a 52 week low of $1.51 and a 52 week high of $12.00.

AirSculpt Technologies (NASDAQ:AIRS) last announced its quarterly earnings data on Thursday, April 2nd. The company reported $0.02 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.05. The company had revenue of $33.44 million for the quarter, compared to the consensus estimate of $34.93 million. AirSculpt Technologies had a negative return on equity of 14.30% and a negative net margin of 11.41%.AirSculpt Technologies’s quarterly revenue was down 14.8% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.09) EPS. As a group, analysts expect that AirSculpt Technologies will post -0.01 earnings per share for the current year.

Insiders Place Their Bets

In related news, major shareholder Jorey Chernett bought 90,000 shares of the stock in a transaction on Friday, April 3rd. The stock was bought at an average price of $2.82 per share, for a total transaction of $253,800.00. Following the completion of the acquisition, the insider directly owned 6,933,761 shares in the company, valued at approximately $19,553,206.02. This represents a 1.32% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders acquired a total of 690,150 shares of company stock worth $1,658,224 in the last ninety days. 76.58% of the stock is owned by corporate insiders.

Institutional Trading of AirSculpt Technologies

A number of hedge funds have recently bought and sold shares of the stock. Larson Financial Group LLC lifted its holdings in AirSculpt Technologies by 20.4% during the third quarter. Larson Financial Group LLC now owns 15,137 shares of the company’s stock worth $121,000 after buying an additional 2,561 shares during the period. Wexford Capital LP lifted its holdings in AirSculpt Technologies by 2.6% during the third quarter. Wexford Capital LP now owns 102,614 shares of the company’s stock worth $823,000 after buying an additional 2,614 shares during the period. Rhumbline Advisers lifted its holdings in AirSculpt Technologies by 16.1% during the third quarter. Rhumbline Advisers now owns 20,782 shares of the company’s stock worth $167,000 after buying an additional 2,876 shares during the period. Creative Planning lifted its holdings in AirSculpt Technologies by 32.2% during the second quarter. Creative Planning now owns 13,225 shares of the company’s stock worth $64,000 after buying an additional 3,224 shares during the period. Finally, BNP Paribas Financial Markets lifted its holdings in AirSculpt Technologies by 239.5% during the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock worth $48,000 after buying an additional 4,199 shares during the period. Hedge funds and other institutional investors own 91.54% of the company’s stock.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.